BabakEdrakiMD
Obstetrics & Gynecology • Walnut Creek, CACritical Care Medicine, General Gynecology, Gynecologic Oncology
Physician
Are you Dr. Edraki?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 65 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1479 Ygnacio Valley Rd
Walnut Creek, CA 94598Phone+1 925-627-3440Fax+1 925-627-3450
Summary
- Dr. Babak Edraki, MD is an obstetrician/gynecologist in Walnut Creek, California. He is currently licensed to practice medicine in California, New Jersey, and Texas. He is affiliated with John Muir Medical Center, Walnut Creek, John Muir Medical Center, Concord, and San Ramon Regional Medical Center.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Obstetrics and Gynecology, 1989 - 1992
Santa Clara Valley Medical CenterInternship, Transitional Year, 1988 - 1989
George Washington University School of Medicine and Health SciencesClass of 1988
Certifications & Licensure
CA State Medical License 1989 - 2026
NJ State Medical License 1997 - 1999
TX State Medical License 1996 - 1998
CT State Medical License 1994 - 1996- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
- Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13
- Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
- Join now to see all
Publications & Presentations
PubMed
- Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over.Omali Pitiyarachchi, Peter J Ansell, Robert L Coleman, Minh H Dinh, Laura Holman
Gynecologic Oncology. 2024-08-01 - 130 citationsRandomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas ...Amanda N. Fader, Dana M. Roque, Eric R. Siegel, Natalia Buza, Pei Hui
Clinical Cancer Research. 2020-08-01 - 9 citationsReal-time Doppler ultrasound to identify vessels and guide needle placement for gynecologic interstitial brachytherapy.Rajni Sethi, Yueh Chun Kuo, Babak Edraki, Dimitry Lerner, Daniel Paik
Brachytherapy. 2018-09-01
Professional Memberships
- Fellow
